About
Immunomedics develops antibody-drug conjugates (ADCs) aimed at treating solid tumors and other cancers.
Explore Immunomedics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Immunomedics develops antibody-drug conjugates (ADCs) aimed at treating solid tumors and other cancers.
Funding rounds, investor list, and risk signals — unlock with a subscription.